Publications by authors named "Flavia Foca"

Claim this Profile
E
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.
Irene Marini, Emilio Francesco Giunta, Silvia Nicolini, Ilaria Grassi, Flavia Foca

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study.
Ilaria Grassi, Silvia Nicolini, Irene Marini, Federica Matteucci, Nicoletta Ranallo, Flavia Foca

Neuroendocrinology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas.
Alberto Bongiovanni, Chiara Liverani, Flavia Foca, Francesca Bergamo, Silvana Leo

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).
Laura Ridolfi, Lorena Gurrieri, Nada Riva, Jenny Bulgarelli, Francesco De Rosa, Flavia Foca

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes.
Romina Rossi, Paola Cravero, Maria Caterina Pallotti, Vanessa Valenti, Ilaria Massa, Flavia Foca

J Pain Symptom Manage· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("" Study).
Alessandro Cafaro, Flavia Foca, Oriana Nanni, Marco Chiumente, Marina Coppola

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).
Alessandro Cafaro, Flavia Foca, Oriana Nanni, Marco Chiumente, Marina Coppola

Front Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients.
Nicola Gentili, William Balzi, Flavia Foca, Valentina Danesi, Mattia Altini

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study.
Isacco Montroni, Giampaolo Ugolini, Nicole M Saur, Siri Rostoft, Antonino Spinelli, Flavia Foca

J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors.
Matelda Medri, Francesco Savoia, Flavia Foca, Anna Miserocchi, Pietro Quaglino

Ital J Dermatol Venerol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
Lorena Gurrieri, Laura Mercatali, Toni Ibrahim, Valentina Fausti, Monia Dall'Agata, Flavia Foca

J Neurooncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer.
Manlio Monti, Andrea Prochowski Iamurri, David Bianchini, Chiara Gallio, Luca Esposito, Flavia Foca

Nutrients· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating hsa-miR-5096 predicts F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors.
Martine Bocchini, Marcella Tazzari, Sara Ravaioli, Filippo Piccinini, Flavia Foca

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frail patients dropping out of neoadjuvant treatment: what should we do?
Paolo Morgagni, Manlio Monti, Leonardo Solaini, Flavia Foca, Giorgio Ercolani

Updates Surg· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors.
Chiara Liverani, Chiara Spadazzi, Toni Ibrahim, Federica Pieri, Flavia Foca

Front Endocrinol (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy and palliative care outpatient clinic: a new healthcare integrated model in Italy.
Romina Rossi, Flavia Foca, Luca Tontini, Martina Pieri, Simona Micheletti

Support Care Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT).
Elisabetta Parisi, Donatella Arpa, Giulia Ghigi, Lucia Fabbri, Flavia Foca

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin.
Valentina Fausti, Alessandro De Vita, Silvia Vanni, Virginia Ghini, Lorena Gurrieri, Flavia Foca

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials.
Alberto Bongiovanni, Silvia Nicolini, Toni Ibrahim, Flavia Foca, Maddalena Sansovini

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.
Valentina Danesi, Ilaria Massa, Flavia Foca, Angelo Delmonte, Lucio Crinò

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-T magnetic resonance-guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors.
Alberto Bongiovanni, Flavia Foca, Devil Oboldi, Danila Diano, Alberto Bazzocchi

Support Care Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study.
Isacco Montroni, Giampaolo Ugolini, Nicole M Saur, Siri Rostoft, Antonino Spinelli, Flavia Foca

J Natl Cancer Inst· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.
Nicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, Chiara Liverani, Alessandro De Vita

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial.
Alessandro Passardi, Flavia Foca, Orazio Caffo, Carlo Alberto Tondini, Alberto Zambelli

J Med Internet Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in -Mutated Non-Small Cell Lung Cancer.
Francesca Fanini, Erika Bandini, Meropi Plousiou, Silvia Carloni, Petra Wise, Flavia Foca

Int J Mol Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis